Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clementine Nordon

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 23, 2016
The "Efficacy-Effectiveness Gap": Historical Background and Current ConceptualizationClementine Nordon, Helene Karcher, Rolf H H Groenwold, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 17, 2025
Characteristics and Outcomes of People With COPD Who Experience Exacerbations While on Inhaled Triple Therapy: Results of the SIRIUS I Cohort Study in the US (2015-2019)Clementine Nordon, Donna Carstens, Malin Fagerås, et al.
Scientific Reports|February 19, 2021
Decongestant use and the risk of myocardial infarction and stroke: a case-crossover studyLamiae Grimaldi-Bensouda, Bernard Begaud, Jacques Benichou, et al.
European Journal of Internal Medicine|May 10, 2024
Cardiovascular events after exacerbations of chronic obstructive pulmonary disease: Results from the EXAcerbations of COPD and their OutcomeS in CardioVascular diseases study in ItalySilvia Calabria, Giulia Ronconi, Letizia Dondi, et al.
Journal of Alzheimer'S Disease : JAD|July 28, 2020
Health Outcome Prioritization in Alzheimer's Disease: Understanding the Ethical LandscapeAlex McKeown, Andrew Turner, Zuzanna Angehrn, et al.
BMJ Open|May 15, 2023
EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studiesClementine Nordon, Kirsty Rhodes, Jennifer K Quint, et al.
American Journal of Respiratory and Critical Care Medicine|December 21, 2023
Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based StudyEmily L Graul, Clementine Nordon, Kirsty Rhodes, et al.
BMC Pulmonary Medicine|May 4, 2024
Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control studyEmily L Graul, Clementine Nordon, Kirsty Rhodes, et al.
ERJ Open Research|June 17, 2025
The sustained increase of cardiovascular risk following COPD exacerbations: meta-analyses of the EXACOS-CV studiesClementine Nordon, Sami O Simons, Jonathan Marshall, et al.
Stroke|July 13, 2021
Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk FactorsLamiae Grimaldi-Bensouda, Jean-Yves Le Heuzey, Jean Ferrières, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 23, 2016
The "Efficacy-Effectiveness Gap": Historical Background and Current ConceptualizationClementine Nordon, Helene Karcher, Rolf H H Groenwold, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 17, 2025
Characteristics and Outcomes of People With COPD Who Experience Exacerbations While on Inhaled Triple Therapy: Results of the SIRIUS I Cohort Study in the US (2015-2019)Clementine Nordon, Donna Carstens, Malin Fagerås, et al.
Scientific Reports|February 19, 2021
Decongestant use and the risk of myocardial infarction and stroke: a case-crossover studyLamiae Grimaldi-Bensouda, Bernard Begaud, Jacques Benichou, et al.
European Journal of Internal Medicine|May 10, 2024
Cardiovascular events after exacerbations of chronic obstructive pulmonary disease: Results from the EXAcerbations of COPD and their OutcomeS in CardioVascular diseases study in ItalySilvia Calabria, Giulia Ronconi, Letizia Dondi, et al.
Journal of Alzheimer'S Disease : JAD|July 28, 2020
Health Outcome Prioritization in Alzheimer's Disease: Understanding the Ethical LandscapeAlex McKeown, Andrew Turner, Zuzanna Angehrn, et al.
BMJ Open|May 15, 2023
EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studiesClementine Nordon, Kirsty Rhodes, Jennifer K Quint, et al.
American Journal of Respiratory and Critical Care Medicine|December 21, 2023
Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based StudyEmily L Graul, Clementine Nordon, Kirsty Rhodes, et al.
BMC Pulmonary Medicine|May 4, 2024
Factors associated with non-fatal heart failure and atrial fibrillation or flutter within the first 30 days post COPD exacerbation: a nested case-control studyEmily L Graul, Clementine Nordon, Kirsty Rhodes, et al.
ERJ Open Research|June 17, 2025
The sustained increase of cardiovascular risk following COPD exacerbations: meta-analyses of the EXACOS-CV studiesClementine Nordon, Sami O Simons, Jonathan Marshall, et al.
Stroke|July 13, 2021
Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk FactorsLamiae Grimaldi-Bensouda, Jean-Yves Le Heuzey, Jean Ferrières, et al.
Pageof 5